Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Can J Cardiol ; 26(1): 35-6, 2010 Jan.
Article in English | MEDLINE | ID: mdl-20101355

ABSTRACT

Coronary computed tomography angiography (CCTA) is becoming an increasingly robust tool in the assessment and exclusion of coronary artery disease. Multiple recent studies have raised concerns regarding the radiation dose exposure of CCTA. A novel approach to dose reduction in CCTA using adaptive statistical iterative reconstruction, resulting in a submillisievert CCTA examination, is described. To the authors' knowledge, the present report describes the first submillisievert study performed in Canada. The ability to perform a diagnostic CCTA with such a low dose challenges the role of coronary calcium scoring and will likely have implications for the future use of this test.


Subject(s)
Coronary Angiography/methods , Tomography, X-Ray Computed , Contrast Media , Humans , Image Processing, Computer-Assisted , Male , Middle Aged , Radiation Dosage , Triiodobenzoic Acids
3.
Int J Clin Pharmacol Ther ; 34(6): 231-5, 1996 Jun.
Article in English | MEDLINE | ID: mdl-8793609

ABSTRACT

Congestive heart failure is associated with high morbidity and mortality. Modification of neurohormonal activation by use of angiotensin converting enzyme inhibitors has been shown to decrease symptoms and prolong survival. More recent evidence has suggested that beta-adrenoceptor blocking agent therapy may be also beneficial in patients with congestive heart failure, possibly by down-regulating the activation of the adrenergic system. A large number of randomized trials of beta-adrenoceptor blocking agents in heart failure have been performed. These studies demonstrated improvement in symptoms of congestive heart failure, functional classification, and reduction in the number of patients requiring cardiac transplantation. beta-adrenoceptor blocking agents have not been shown to decrease mortality, however, the current trials have been too small to be conclusive in this regard.


Subject(s)
Adrenergic beta-Antagonists/therapeutic use , Heart Failure/drug therapy , Heart Failure/physiopathology , Humans
SELECTION OF CITATIONS
SEARCH DETAIL
...